Please notice!
This website uses cookies to provide necessary site functionality and improve your online experience. By using this website, you agree to the use of cookies as outlined in the
Privacy Statement
.

For exact search enclose your search term with "quotation marks". Enter an "AND" between multiple search terms. Add an " * " behind your search term for full wildcard search.

Get in touch!

Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.

Miltenyi Biotec distribution:

As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is
committed to providing our customers around the world with the highest quality products.
In addition to direct selling in more than 20 countries in North America, Europe and
Asia/Pacific, Miltenyi Biotec also provides support for our customers through an
extensive distributor network covering dozens of additional countries.

As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is
committed to providing our customers around the world with the highest quality products.
In addition to direct selling in more than 20 countries in North America, Europe and
Asia/Pacific, Miltenyi Biotec also provides support for our customers through an
extensive distributor network covering dozens of additional countries.

Hematopoietic stem cells

1 Introduction

Hematopoietic stem cells (HSC) are tissue-specific adult stem cells capable of differentiating into all blood cell types to ensure homeostasis of blood throughout life.

Research on murine HSCs dates back to the late 1940s/early 1950s, when it was discovered that sub-lethally irradiated mice could be rescued from hematopoietic failure by injecting cells from blood-forming organs, such as the bone marrow. This finding led to the idea that cells in bone marrow with repopulation capacity could be further characterized and quantified in transplantation models. In early experiments, decreasing numbers of bone marrow cells were injected into recipient mice to determine the lowest cell number needed to fully reconstitute hematopoiesis. Further experiments transplanting sub-radioprotective doses of bone marrow cells into mice showed that these mice developed colonies of hematopoietic cells in their spleens. The number of colonies correlated to the amount of bone marrow cells originally injected. The advent of fluorescence-activated cell sorting technology and monoclonal antibodies then finally led to the identification of surface markers which are used to identify mouse HSCs.

Related PDFs:

2 HSCs in bone marrow

The main source to isolate mouse HSCs is bone marrow, where they represent approx. 0.01% of the total cells.

2.1 Cell subsets, frequencies, and marker expression

At a glance: HSCs in bone marrow

HSC source

Frequency

Marker expression

Function

Bone marrow

0.01%

Lin–Sca-1+CD117+CD48–CD150+

Hematopoiesis

Mouse HSCs are characterized and/or isolated using several surface markers. Firstly, mouse HSCs lack the expression of lineage-specific markers (meaning that they are are lin–), and are positive for c-kit (CD117) and Sca-1. More recently, the HSC population was further narrowed down by including CD150 and CD48, resulting in the marker profile Lin–c-Kit+Sca-1+CD48–CD150+.

2.2 Miltenyi Biotec application protocols for HSCs from bone marrow

Miltenyi Biotec has created dedicated application protocols to work with and analyze HSCs.

Direct Lineage Cell Depletion Kit, mouse

Before separation

After separation

LSK staining

Quick, one-step separation of lineage-negative cells. Untouched lineage-negative cells were isolated from a single-cell suspension of mouse bone marrow using the Direct Lineage Cell Depletion Kit, mouse and a MidiMACS™ Separator with an LS Column. Cells were fluorescently stained with Lineage Cell Detection Cocktail-Biotin and Anti-Biotin-APC and analyzed by flow cytometry using the MACSQuant® Analyzer. To evaluate the LSK (Lin–Sca-1+c-kit+) fraction, cells were further stained with CD117-PE (c-kit) and Anti-Sca-1-FITC. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.

Enriched murine hematopoietic progenitor cells. Lineage–CD117+ cells were isolated from mouse bone marrow using the Lineage Cell Depletion Kit, CD117 MicroBeads, an LS Column, and a MidiMACS Separator. The cells were fluorescently stained with CD117-PE and Anti-Biotin-APC against the panel of biotinylated antibodies used for the Lineage Cell Depletion Kit, mouse. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.

Enriched murine hematopoietic progenitor cells.

Lineage–CD117+ cells were isolated from mouse bone marrow using the Lineage Cell Depletion Kit, CD117 MicroBeads, an LS Column, and a MidiMACS Separator. The cells were fluorescently stained with CD117-PE and Anti-Biotin-APC against the panel of biotinylated antibodies used for the Lineage Cell Depletion Kit, mouse. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.

HSCs are routinely analyzed by flow cytometry based on various extracellular and intracellular markers. The Lineage Cell Detection Cocktail-Biotin, mouse simplifies the flow cytometry analysis of cells before and after cell separation using MACS Technology. All antibodies are optimally titrated to be simply added to an aliquot of a cell fraction before analysis.

Miltenyi Biotec also offers a wide range of unique and standard monoclonal antibodies for research of HSCs and progenitor cells, including CD117, Anti-SCA-1, CD150, and CD48. Fluorochrome-conjugated MACS Antibodies are perfectly suited for the identification, enumeration, and characterization of HSCs, which can be combined into panels tailored to specific research needs. An online tool to quickly build an appropriate multicolor flow cytometry panel for each research project is available through the Related resources panel to the right.

Isolated mouse HSCs can be further expanded in cell culture with HSC-relevant growth factors to obtain a larger number of cells or to elucidate mechanisms and signaling pathways driving self-renewal or differentiation. Early acting cytokines – mouse stem cell factor (SCF), Flt3-Ligand, and interleukin-6 (IL-6) – expand primitive HSCs, although current HSC culture systems allow only limited expansion and maintenance of primitive HSCs that can engraft and completely restore the entire blood system.

2.6.2 Viral transduction of HSCs

Viral transduction is a fast and efficient method to study gene function or modulate gene expression. It is also a potential approach for gene modification in the context of gene therapies. Transduction of HSCs is especially interesting because of the cells' potential to eliminate hematopoietic defects. The modification of HSCs with retroviral vectors often requires the presence of a transduction-enhancing reagent. Polycationic reagents induce aggregation of vector particles and facilitate binding of the vectors to target cells via electrostatic interaction. Bridging molecules, such as recombinant fibronectin, interact with both vector particles and cell membrane. Transduction performance can be enhanced by centrifugation.

Miltenyi Biotec offers the novel transduction enhancer Vectofusin-1®, a fully synthetic non-toxic cationic amphipathic peptide that supports high transduction levels with small amounts of retroviral vector. When added to culture medium, Vectofusin-1 promotes the entry of several retroviral pseudo-types into target cells.